HealthTech Capital

Type

Angel Group/Syndicate

Status

Active

Location

Los Altos, United States

Total investments

86

Average round size

2M

Portfolio companies

55

Rounds per year

6.14

Lead investments

4

Follow on index

0.35

Exits

7

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceMachine LearningFitnessHealth CareWellnessMedical DeviceMedicalPersonal Health

Summary

In 2010 was created HealthTech Capital, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Los Altos Hills.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the HealthTech Capital, startups are often financed by Rock Health, Sand Hill Angels, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are Sand Hill Angels, Adams Street Partners, The Westly Group. In the next rounds fund is usually obtained by The Westly Group, Sand Hill Angels, Adams Street Partners.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are mHealth, Wearables. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Neocis, InfoBionic.

The fund was created by Anne DeGheest.

The higher amount of exits for fund were in 2018. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. This HealthTech Capital works on 18 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The average startup value when the investment from HealthTech Capital is 1-5 millions dollars. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.

Show more

Investor highlights

Industry focus
HealthcareConsumer/Retail
Stage focus
Series BSeries ASeed
Geo focus
United States

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
86
Lead investments
4
Exits
7
Rounds per year
6.14
Follow on index
0.35
Investments by industry
  • Health Care (69)
  • Medical Device (25)
  • Biotechnology (21)
  • Medical (18)
  • Software (14)
  • Show 52 more
Investments by region
  • United States (84)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
15M
Group Appearance index
0.53
Avg. company exit year
4
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
De Oro Devices 01 Dec 2021 Health Care, Health Diagnostics, Medical Device Seed United States, California, San Luis Obispo
GT Metabolic Solutions 12 Mar 2024 Manufacturing, Medical Early Stage Venture 9M United States, Minnesota, Minneapolis

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.